Pharmaceutical

BIO-Europe 2023: EU HTA harmonisation may land off key ...

Heading towards 2025, pharmaceutical companies have begun preparing for the har...

Putting compliance and quality at the heart of pharmace...

Innovative technology that can improve supply chain visibility, streamline work...

Biotech accelerator Blackbird Labs launches with $100m ...

New life sciences accelerator Blackbird Labs has launched with a $100m grant fr...

eCOA roadmap: Five key steps to patient-focused drug de...

Earlier this year, the FDA released its fourth and final guidance on the incorp...

STAT+: FTC’s Lina Khan makes a stop at Y Combinator, ho...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to ho...

STAT+: FDA cites cancer links in seeking to withdraw ap...

After years of trying, the U.S. Food and Drug Administration is again seeking to...

Sen. Bernie Sanders moves toward another hearing with p...

Pharma execs may have to explain why they're suing Medicare over price negotiati...

STAT+: Drug shortages and the supply chain are a matter...

The pandemic showed how fragile the supply chain can be. The United States needs...

Your morning biotech news roundup

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Vertex and U.K. at odds over value...

Vertex and a U.K. government agency are at odds again over the value of life-sav...

Opinion: A fertility clinic failure destroyed my chance...

A recent investigation into KindBody, a fast-growing fertility chain, found unsa...

STAT+: Remote patient monitoring helped manage hyperten...

A new study, published Monday, suggests that for patients with high blood pressu...

Pulse oximeters’ inaccuracies in darker-skinned people ...

Twenty-five AGs called on the FDA to take urgent action on pulse oximeters' inac...

Opinion: STAT+: The PATCH Act’s approach to securing me...

The PATCH Act’s recently implemented approach to securing medical devices actual...

Experts talk detecting disease from voice biomarkers wi...

At the Milken Summit, experts talked about using AI to capture voice biomarkers ...

STAT+: Ventyx stock craters after lackluster mid-stage ...

Ventyx Biosciences ended development of an experimental drug for plaque psoriasi...